Literature DB >> 2449591

Immunological consequences of HIV infection: advantage of being low responder casts doubts on vaccine development.

C Martínez-A1, M A Marcos, A de la Hera, C Marquez, J M Alonso, M L Toribio, A Coutinho.   

Abstract

Immunosuppression in AIDS might be due to the immune response rather than to the pathogenicity of the virus. The basis of the immunosuppression could be molecular mimicries involving viral gp-110, CD4 molecules, antibodies, and CD4-acceptor sites. Whether an individual develops auto-immunosuppressive responses or mounts a harmless defence against (or coexists with) the virus follows the general rules of lymphocyte repertoire selection. MHC and V region genes and other polymorphic loci, together with the previous state of the immune system, particularly at early developmental periods, are factors that influence the response. Vaccination against gp 110-HIV might thus protect against infection but at the same time cause auto-immunosuppression and disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2449591     DOI: 10.1016/s0140-6736(88)91244-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

1.  An idiotypic network model of AIDS immunopathogenesis.

Authors:  G W Hoffmann; T A Kion; M D Grant
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

2.  Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160.

Authors:  J A Kovacs; M B Vasudevachari; M Easter; R T Davey; J Falloon; M A Polis; J A Metcalf; N Salzman; M Baseler; G E Smith
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

3.  Seroprevalence and disease association of antineutrophil cytoplasmic autoantibodies and antigens in HIV infection.

Authors:  O A Cornely; S Hauschild; C Weise; E Csernok; W L Gross; B Salzberger; G Fätkenheuer; V Diehl; M Schrappe
Journal:  Infection       Date:  1999 Mar-Apr       Impact factor: 3.553

4.  Antibodies to CD4 in individuals infected with human immunodeficiency virus type 1.

Authors:  M Kowalski; B Ardman; L Basiripour; Y C Lu; D Blohm; W Haseltine; J Sodroski
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

5.  The significance of the pre-challenge immune status of mice for development of retrovirus-induced immunodeficiency syndrome (MAIDS).

Authors:  J H Pavlovitch; M Rizk-Rabin; F Picard; M Marussig; A Halbreich
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

6.  Mechanism for the T4 lymphopenia of AIDS.

Authors:  S Micali
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

7.  From Anti-EBV Immune Responses to the EBV Diseasome via Cross-reactivity.

Authors:  Darja Kanduc; Yehuda Shoenfeld
Journal:  Glob Med Genet       Date:  2020-08-31

Review 8.  Mechanisms of autoimmunity and AIDS: prospects for therapeutic intervention.

Authors:  H Atlan; M J Gersten; P L Salk; J Salk
Journal:  Res Immunol       Date:  1994 Mar-Apr
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.